RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-827
Malaria parasiteP. berghei
Genotype
Genetic modification not successful
DisruptedGene model (rodent): PBANKA_1230700; Gene model (P.falciparum): PF3D7_0615900; Gene product: protein phosphatase, putative
PhenotypeNo phenotype has been described
Last modified: 16 August 2013, 18:55
  *RMgm-827
Successful modificationThe gene/parasite could not be changed/generated by the genetic modification.
The following genetic modifications were attempted Gene disruption
Number of attempts to introduce the genetic modification 2
Reference (PubMed-PMID number) Not published (yet)
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA 676m1cl1 (RMgm-29)
Other information parent line676m1cl1 (RMgm-29) is a reference ANKA mutant line which expresses GFP-luciferase under control of a constitutive promoter. This reference line does not contain a drug-selectable marker (PubMed: PMID: 16242190).
Attempts to generate the mutant parasite were performed by
Name PI/ResearcherJ. Lin; C.J. Janse; S.M. Khan
Name Group/DepartmentLeiden Malaria Research Group
Name InstituteLeiden University Medical Center
CityLeiden
CountryThe Netherlands

  Disrupted: Mutant parasite with a disrupted gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1230700
Gene Model P. falciparum ortholog PF3D7_0615900
Gene productprotein phosphatase, putative
Gene product: Alternative name
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct usedPCR construct double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Click to view information
Click to hide information
Plasmid/construct sequence
Click to view information
Click to hide information
GAACTCGTACTCCTTGGTGACGGGTACCATATATCATTCTACGCATATCCTAAATTTTGC
TTCCAAGTATTCATATTTGTATTTTAAGCTCTGTTTCCTATTTTATTTTTTAAACGGTTT
ATTTCTTAAATTTATATTTTTTTTTATTACACACACATTTCCATACAATCATGTGTGGTT
CTAAAAATGTATGAACATATTTATATAAAAAAAAAATATAATAAAAAATACCAAAGTATA
TTGCTTAATTCCTAATCATACTATTATTCCTTACATTTTAAAATGAAATTTTATAGTTAT
TAATAAAGTAAAAACATTTATTAAATATTTAAATGCACACCTATTTAATATCAAGATATA
TGTAATATTATGCATTCTAATAAAGCTTCTTTATAGTCTTTTTAATTATTATATTGCAGT
AGTAACAACAATTTGTATTATTTTTATTTTTTATGATTATTATTCTTACTTTTGTTGTTA
TTATTATTCAATGATTATATATTATAGATATAATAAAAAAAAATGATAAAAGCTAGTTTC
ACAGTAATTAACAATAACAACTTTGAATATTTTTATTTTATTATAAGCTAAGGAAAAATG
TGTGTCATAAAAAAGGACTATATACATGATTGTAAAATAATCCCACAAATGCATAAATGT
GCGATTATTTATATAACTCCAAACTAATACATGCTAAGAGGTCGACGATGCTTGTAGATG
AGTTAAGCTTAATTCTTTTCGAGCTCTTTATGCTTAAGTTTACAATTTAATATTCATACT
TTAAGTATTTTTTGTAGTATCCTAGATATTGTGCTTTAAATGCTCACCCCTCAAAGCACC
AGTAATATTTTCATCCACTGAAATACCATTAAATTTTCAAAAAAATACTATGCATATAAT
GTTATACATATAAACATAAAACGCCATGTAAATCAAAAAATATATAAAAATATGTATAAA
AATAAATATGCACTAAATATAAGCTAATTATGCATAAAAATTAAAGTGCCCTTTATTAAC
TAGTCGTAATTATTTATATTTCTATGTTATAAAAAAATCCTCATATAATAATATAATTAA
TATATGTAATGTTTTTTTTATTTTATAATTTTAATATAAAATAATATGTAAATTAATTCA
AAAAATAAATATAATTGTTGTGAAACAAAAAACGTAATTTTTTCATTTGCCTTCAAAATT
TAAATTTATTTTAATATTTCCTAAAATATATATACTTTGTGTATAAATATATAAAAATAT
ATATTTGCTTATAAATAAATAAAAATTTTATAAAAATGGTTGGTTCGCTAAACTGCATCG
TCGCTGTGTCCCAGAACATGGGCATCGGCAAGAACGGGGACCTGCCCTGGCCACCGCTCA
GGAATGAATTCAGATATTTCCAGAGAATGACCACAACCTCTTCAGTAGAAGGTAAACAGA
ATCTGGTGATTATGGGTAAGAAGACCTGGTTCTCCATTCCTGAGAAGAATCGACCTTTAA
AGGGTAGAATTAATTTAGTTCTCAGCAGAGAACTCAAGGAACCTCCACAAGGTGCACATT
TTCTTTCCAGAAGTCTAGATGATGCCTTAAAACTTACTGAACAACCAGAATTAGCAAATA
AAGTAGACATGGTCTGGATAGTTGGTGGCAGTTCTGTTTATAAGGAAGCCATGAATCACC
CAGGCCATCTTAAACTATTTGTGACAAGGATCATGCAAGACTTTGAAAGTGACACGTTTT
TTCCAGAAATTGATTTGGAGAAATATAAACTTCTGCCAGAATACCCAGGTGTTCTCTCTG
ATGTCCAGGAGGAGAAAGGCATTAAGTACAAATTTGAAGTATATGAGAAGAATGATTAAT
GTTCGTTTTTCTTATTTATATATTTATACCAATTGATTGTATTTATAACTGTAAAAATGT
GTATGTTGTGTGCATATTTTTTTTTGTGCATGCACATGCATGTAAATAGCTAAAATTATG
AACATTTTATTTTTTGTTCAGAAAAAAAAAACTTTACACACATAAAATGGCTAGTATGAA
TAGCCATATTTTATATAAATTAAATCCTATGAATTTATGACCATATTAAAAATTTAGATA
TTTATGGAACATAATATGTTTGAAACAATAAGACAAAATTATTATTATTATTATTATTTT
TACTGTTATAATTATGTTGTCTCTTCAATGATTCATAAATAGTTGGACTTGATTTTTAAA
ATGTTTATAATATGATTAGCATAGTTAAATAAAAAAAGTTGAAAAATTAAAAAAAAACAT
ATAAACACAAATGATGTTTTTTCCTTCAATTTCGGATCCACTAGCAAGAGAAATGAAGGA
ACAGATTTCGATAAGCAATGATTTAAATGATTGGATCATAAAAATAAATAAATATATTTT
AAAAGAAGATGGAAAACAAATAAATATAGGCAATGTTCCATTTAATTTAATTAAATTTAA
CAGATTATATGAATGTTTACACCCATGCAGAGTAATAGGTGATTATGATTTAAAAGGGAA
ATGTAATGATTCAAATTTTATTTTGTCTAACAATTCTAATATATATAAATATGACATGAA
TAATATAAATTTGATTAATAATATTCATTATATTTATAAAATACAAAAATGTATAAATTG
CAAAATGATATATTTATTGAATAGTTATGGAAAAATAAATTCAATCAAAAATATTGCTTT
ACTTAATACGAAAAGCGAATTATATCAAAATAGTAACATACTTGTAAATTACATTGAAAA
AGAACAAACAAACGATTGTTGTAATAATGTGATAGATAAATATGAAAGTTATAATTCCTT
TGAAGAAAAACTTGAAAGTATTATGACCATTTATAAAGACAATGAAAATATTAATGACTC
TAAAAAAATGAAAAAAAAAAATACTAACTTATGTTTGAATGAATCATTATCTCCATATTT
GCATATTAAAAATAATTCATTAAATAAAAATTATGTATATCGATCAGGAAAAAAAGAAAA
CAAACATTTTTTTCATTTGCTAATTATCGCATCGGAAGTACTGCTGAGTGTCAATGACCA
ACCT
Restriction sites to linearize plasmid
Partial or complete disruption of the geneComplete
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationThe protein contains the following domain: IPR001932 - Protein phosphatase 2C-related (pp2c).

Several unsuccessful attempts to disrupt the gene (exp 1782 and 1957 with PCR constructs 1782 and 1957 respectively).

The unsuccessful attempts indicate an essential role during blood stage development/multiplication.

The locus was unsuccessfully targeted using a linear construct that was generated using a 2-step, anchor tagging PCR method (for primer details see below).

The 5’- and 3’ targeting regions of the gene were PCR amplified from genomic DNA using primer pairs 1&2 and 3&4. Primers 2 and 3 have 5’-terminal extensions homologues to the hDHFR selectable marker cassette. Primers 1 and 4 both have a 5’-terminal overhang with an anchor-tag which serves as a primer site in the 2nd PCR reaction.

The target fragments from the first PCR reaction were annealed to either side of the selectable marker cassette by PCR with anchor-tag primers 5 and 6, resulting in the 2nd PCR product. The hDHFR selectable marker cassette used in this reaction was digested from pL0040 using restriction enzymes XhoI and NotI. pL0040 is available from The Leiden Malaria Research Group.

To remove the anchor-tags from the final KO construct, and to eliminate contaminating pL0040, the 2nd PCR product was digested with Asp718/ScaI and DpnI respectively. DpnI only cuts methylated plasmid DNA but not the PCR product.

For a more detailed understanding of the 2-step anchor tagging PCR method, please see the following publications:

J.W. Lin, S.M. Khan et al
A novel 'gene insertion/marker out' (GIMO) method for transgene expression and gene complementation in rodent malaria parasites
PLoS One. 2011;6(12)

T. Annoura et al
Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates
Vaccine. 2012 Mar 30;30(16):2662-70

One more unsuccessful attempt to disrupt the gene was carried out using a second linear construct that was generated using a 2-step, anchor tagging PCR method. This construct (PCR1827) used the same targeting regions but differed by having the hdhfr::yfcu selectable marker cassette. The attempt was made in the WT cl15cy1 background.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1GAACTCGTACTCCTTGGTGACGGGTACCATATATCATTCTACGCATATCC
Additional information primer 1L5844: 5’- pp2c targeting region F (Asp718)
Sequence Primer 2CATCTACAAGCATCGTCGACCTCTTAGCATGTATTAGTTTGGAG
Additional information primer 2L5845: 5’- pp2c targeting region R
Sequence Primer 3CCTTCAATTTCGGATCCACTAGCAAGAGAAATGAAGGAACAG
Additional information primer 3L4725: 3’- pp2c targeting region F
Sequence Primer 4AGGTTGGTCATTGACACTCAGCAGTACTTCCGATGCGATAATTAGC
Additional information primer 4L4673: 3’- pp2c targeting region R (ScaI)
Sequence Primer 5GAACTCGTACTCCTTGGTGACG
Additional information primer 5L4661; anchor tag primer
Sequence Primer 6AGGTTGGTCATTGACACTCAGC
Additional information primer 6L4662: anchor tag primer